Radiology Journals

Radiology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Barbaro D et al. – RhTSH is highly effective for post–surgical thyroid remnant ablation in low–risk cancer patients using the low 30–mCi dose protocol combined with the short 4–day withdrawal of L–T4. Moreover, in these patients the pre–treatment with furosemide seems to play an important role to further improve the outcome of ablation by reducing the iodine pool.

Related Articles

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09    Relevance Score: 68%

Molecular Diagnostics and Predictors in Thyroid Cancer
Thyroid, 11/19/09    Relevance Score: 67%

Thyroid Cancer in Systemic Lupus Erythematosus: A Case-Control Study
Journal of Clinical Endocrinology and Metabolism, 11/12/09    Relevance Score: 67%

Neurofibroma adjacent to the thyroid gland and a thyroid papillary carcinoma in a patient with neurofibromatosis type 1: Report of a case
Surgery Today, 10/06/09    Relevance Score: 67%

Increasing Detection and Increasing Incidence in Thyroid Cancer
World Journal of Surgery, 10/05/09    Relevance Score: 67%

Today in Nuclear Medicine...keeping you current

Radioisotopic Imaging of Neuroinflammation
The Journal of Nuclear Medicine, 12/17/09

Diagnosis of Cirrhotic Portal Hypertension and Compensatory Circulation Using Transsplenic Portal Scintigraphy with 99mTc-Phytate
The Journal of Nuclear Medicine, 12/17/09

18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
The Journal of Nuclear Medicine, 12/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address